Ivicentamab
Ivicentamab (GEN-3009) is an IgG1κ-type bispecific antibody targeting different epitopes of CD37. Ivicentamab can be used for cancer research[1].
Product Specifications
CAS Number
2364496-42-2
Product Name Alternative
GEN-3009
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ivicentamab.html
Purity
99.82
Solubility
10 mM in DMSO
Smiles
[Ivicentamab]
Molecular Weight
(144.88 kDa)
References & Citations
[1]Balocco Mattavelli. International Nonproprietary Names Programme and Classification of Medical Products. World Health Organization International Nonproprietary Names.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-2940R-BF647-TR 20 µL
FUCA1 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details 
CSB-EP358889ENV-01 10 µg
Recombinant Escherichia coli Integration host factor subunit alpha (ihfA)
Sign In for Pricing
View Details CSB-EP358889ENV-02 50 µg
Recombinant Escherichia coli Integration host factor subunit alpha (ihfA)
Sign In for Pricing
View Details CSB-EP358889ENV-03 200 µg
Recombinant Escherichia coli Integration host factor subunit alpha (ihfA)
Sign In for Pricing
View Details CSB-EP358889ENV-04 500 µg
Recombinant Escherichia coli Integration host factor subunit alpha (ihfA)
Sign In for Pricing
View Details CSB-EP358889ENV-05 20 µg
Recombinant Escherichia coli Integration host factor subunit alpha (ihfA)
Sign In for Pricing
View Details